Advertisement

Topics

DaVita, Inc. Company Profile

13:00 EST 21st February 2019 | BioPortfolio

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of September 30, 2011, DaVita operated or provided administrative services at 1,777 dialysis facilities, serving approximately 138,000 patients. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit www.davita.com.


News Articles [23 Associated News Articles listed on BioPortfolio]

12th Annual Tour DaVita Raises $1.1M for Bridge of Life

DENVER, Oct. 5, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, today announced Tour DaVita, Read more...

DaVita Named to Dow Jones Sustainability World Index

DENVER, Oct. 24, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the Read more...

To Win Over FTC, DaVita Sale Price To UnitedHealth Drops To $4.3B

UnitedHealth Group will pay nearly$600 million less for DaVita Medical Group in an effort to satisfy the Federal Trade Commission and close the acquisition.

DaVita Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

DaVita Inc. Strategy, SWOT and Corporate Finance ReportSummaryDaVita Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th...

DaVita to pay $270 million to end U.S. probe into Medicare payments

A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain...

DaVita resolves U.S. probe into Medicare payments for $270 million

A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain ...

Dialysis Giant DaVita Defends Itself In Court And At The Polls

Although dialysis provider DaVita Inc. has taken major financial hits this year, including a $383.5 million jury award in response to wrongful death lawsuits, it still rakes in profits. The company fa...

DaVita unit to pay $270 million to resolve Medicare payments probe

A medical care unit of DaVita Inc has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

DaVita Assessment of Nutritional Supplement Effects (DANSE)

This is a Phase IV randomized controlled study assessing the effectiveness of a commercially available nutritional supplement on malnourished prevalent hemodialysis patients. Patients wil...

Companies [10 Associated Companies listed on BioPortfolio]

DaVita Labs

DaVita Labs, a division operating within DaVita Inc., provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As ...

DaVita, Inc.

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end sta...

DaVita Inc.

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failu...

DaVita HealthCare Partners Inc.

DaVita HealthCare Partners, a Fortune 500® company, is the parent company of DaVita and HealthCare Partners. DaVita is a leading provider of kidney care in the United States, d...

DaVita HealthCare Partners

DaVita HealthCare Partners, a Fortune 500® company, is the parent company of DaVita and HealthCare Partners. DaVita is a leading provider of kidney care in the United States, d...

More Information about "DaVita, Inc." on BioPortfolio

We have published hundreds of DaVita, Inc. news stories on BioPortfolio along with dozens of DaVita, Inc. Clinical Trials and PubMed Articles about DaVita, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DaVita, Inc. Companies in our database. You can also find out about relevant DaVita, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...


Corporate Database Quicklinks



Searches Linking to this Company Record